Rare genetic variants suggest dysregulation of signaling pathways in low- and high-risk patients developing severe ovarian hyperstimulation syndrome.


Journal

Journal of assisted reproduction and genetics
ISSN: 1573-7330
Titre abrégé: J Assist Reprod Genet
Pays: Netherlands
ID NLM: 9206495

Informations de publication

Date de publication:
Nov 2020
Historique:
received: 11 06 2020
accepted: 07 09 2020
pubmed: 19 9 2020
medline: 4 6 2021
entrez: 18 9 2020
Statut: ppublish

Résumé

To investigate if rare gene variants in women with severe ovarian hyperstimulation syndrome (OHSS) provide clues to the mechanisms involved in the syndrome. Among participants in a prospective randomized study (Toftager et al. 2016), six women with predicted low and six women with predicted high risk of OHSS developing severe OHSS (grades 4 and 5, Golan classification) were selected. In the same cohort, six plus six matched controls developing no signs of OHSS (Golan grade 0) were selected. Whole-exome sequencing was performed. Analysis using a predefined in silico OHSS gene panel, variant filtering, and pathway analyses was done. We found no convincing monogenetic association with the development of OHSS using the in silico gene panel. Pathway analysis of OHSS variant lists showed substantial overlap in highly enriched top pathways (p value range p < 0.0001 and p > 9.8E-17) between the low- and high-risk group developing severe OHSS, i.e., "the integrin-linked kinase (ILK) signaling pathway" and the "axonal guidance signaling pathway," both being connected to vasoactive endothelial growth factor (VEGF) and endothelial function. Rare variants in OHSS cases with two distinct risk profiles enrich the same signaling pathways linked to VEGF and endothelial function. Clarification of the mechanism as well as potentially defining genetic predisposition of the high vascular permeability is important for future targeted treatment and prevention of OHSS; the potential roles of ILK signaling and the axonal guidance signaling need to be validated by functional studies.

Identifiants

pubmed: 32945993
doi: 10.1007/s10815-020-01941-0
pii: 10.1007/s10815-020-01941-0
pmc: PMC7642034
doi:

Substances chimiques

Chorionic Gonadotropin 0
Endothelial Growth Factors 0
VEGFA protein, human 0
Vascular Endothelial Growth Factor A 0
integrin-linked kinase EC 2.7.1.-
Protein Serine-Threonine Kinases EC 2.7.11.1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2883-2892

Références

Cold Spring Harb Perspect Biol. 2010 May;2(5):a001875
pubmed: 20452960
Mol Reprod Dev. 2019 Aug;86(8):964-971
pubmed: 31115963
Int J Reprod Biomed. 2017 Feb;15(2):87-92
pubmed: 28462400
Front Endocrinol (Lausanne). 2019 May 14;10:305
pubmed: 31139153
OMICS. 2012 May;16(5):284-7
pubmed: 22455463
Bioinformatics. 2004 Dec 12;20(18):3710-5
pubmed: 15297299
Reprod Biomed Online. 2009 Jun;18(6):743-9
pubmed: 19490776
BMC Genomics. 2015 Apr 03;16:264
pubmed: 25888426
Front Physiol. 2019 Mar 12;10:224
pubmed: 30930791
Aust N Z J Obstet Gynaecol. 2016 Dec;56(6):624-627
pubmed: 27531056
Hum Reprod. 2016 Sep;31(9):1997-2004
pubmed: 27343272
Gynecol Endocrinol. 2015;31(8):587-9
pubmed: 26190539
J Assist Reprod Genet. 2019 Mar;36(3):491-497
pubmed: 30483911
J Leukoc Biol. 2018 Apr;103(4):749-759
pubmed: 29360169
BMC Genomics. 2019 Apr 5;20(1):273
pubmed: 30953450
Reproduction. 2018 Apr;155(4):R183-R198
pubmed: 29374086
Endocrine. 2005 Apr;26(3):285-90
pubmed: 16034183
Obstet Gynecol Int. 2015;2015:514159
pubmed: 26074966
Hum Reprod. 2020 May 1;35(5):1230-1245
pubmed: 32378719
Mol Hum Reprod. 2012 Dec;18(12):572-84
pubmed: 22923488
Eur J Cell Biol. 2012 Jun-Jul;91(6-7):472-85
pubmed: 22138087
J Physiol. 2015 Feb 1;593(3):601-18; discussion 618
pubmed: 25398526
Curr Hypertens Rep. 2010 Aug;12(4):267-75
pubmed: 20532699
Cochrane Database Syst Rev. 2017 Jan 23;1:CD012103
pubmed: 28111738
JBRA Assist Reprod. 2020 May 01;24(2):104-114
pubmed: 32155011
Int J Fertil Womens Med. 2007 Jan-Feb;52(1):11-26
pubmed: 17987884
Acta Endocrinol (Copenh). 1977 Oct;86(2):380-3
pubmed: 578626
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
Hum Reprod. 1997 Dec;12(12):2629-34
pubmed: 9455826
Hum Reprod. 2007 Jun;22(6):1647-51
pubmed: 17356124
J Turk Ger Gynecol Assoc. 2012 Jun 01;13(2):142-4
pubmed: 24592025
Hum Reprod. 2016 Jun;31(6):1253-64
pubmed: 27060174
BMC Genomics. 2014 Jan 14;15:24
pubmed: 24422759
Reproduction. 2017 Oct;154(4):355-362
pubmed: 28676533
Ultrasound Obstet Gynecol. 2015 Apr;45(4):377-93
pubmed: 25302750
EPMA J. 2019 Jun 8;10(2):153-172
pubmed: 31258820
Mol Med Rep. 2017 Jul;16(1):272-280
pubmed: 28534980
Hum Reprod. 2008 Mar;23(3):662-7
pubmed: 18216038
Reprod Biomed Online. 2016 Mar;32(3):274-85
pubmed: 26803205
Semin Reprod Med. 2010 Nov;28(6):448-57
pubmed: 21082502
Reprod Biol Endocrinol. 2018 Feb 20;16(1):15
pubmed: 29463248
EMBO J. 2019 Jan 15;38(2):
pubmed: 30518533

Auteurs

L Borgwardt (L)

Centre for Genomic Medicine, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark. Line.gutte.borgwardt@regionh.dk.

K W Olsen (KW)

Department of Obstetrics and Gynaecology, Fertility Clinic, Copenhagen University Hospital, Herlev, Denmark.

M Rossing (M)

Centre for Genomic Medicine, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.

R Borup Helweg-Larsen (RB)

Functional Genomics and Reproductive Health Group, Faculty of Health and Medical Sciences- Copenhagen University, Copenhagen, Denmark.

M Toftager (M)

Department of Obstetrics and Gynaecology, Fertility Clinic, Copenhagen University Hospital, Hvidovre, Denmark.

A Pinborg (A)

Fertility Clinic, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.

J Bogstad (J)

Department of Obstetrics and Gynaecology, Fertility Clinic, Copenhagen University Hospital, Hvidovre, Denmark.

K Løssl (K)

Department of Obstetrics and Gynaecology, Fertility Clinic, Copenhagen University Hospital, Hvidovre, Denmark.

A Zedeler (A)

Department of Obstetrics and Gynaecology, Fertility Clinic, Copenhagen University Hospital, Hvidovre, Denmark.

M L Grøndahl (ML)

Department of Obstetrics and Gynaecology, Fertility Clinic, Copenhagen University Hospital, Herlev, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH